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The complex of the immunosuppressant FK506 bound to FKBP-I? has been studied in solution using ‘H and inverse-detected “C NMR methods. 
The resonances of bound, “C-1abellcd FK506 were assigned and a set of 66 inttaligand NOE distance restraints were used to calculate the structure 
of the bound ligdnd by distance geometry and restrained molecular dynamics methods. The structure of bound FKS06 in solution closely resembles 
that seen in the X-ray structure [171, except for the ally1 region. The differences reflect he inlluencc ol’ intermolecular crystal contacts and have 
implications for interpretation of the internction of the FKSOBlFKBP complex with its putalive biological receptor. 
FK506; FKBP: Peptidyl-prolyl cismnts isomcrasc; NMR; Immunophilin 
1. INTRODUCTION 
FK506 and cyclosporin (GA) are potent immuno- 
suppressants that have been shown to inhibit signal 
transduction pathways leading to T-cell activation [l]. 
These drugs appear to act in the early stages of T-cell 
activation by blocking pathways leading to transcrip- 
tion of IL-2 genes [2-51. The major binding proteins for 
these dmgs, termed immunophilins. are the FK506 
binding protein (FKBP-12) and cyclophilin (CyP), re- 
spectively. Recently it has been shown that a calcium 
and calmodulin dependent protein phosphatase, cal- 
cineurin, binds and is inhibited by t3e binary complexes 
of FKSOB with FKBP-12 and cyclosporin with cyclo- 
philin [6]. 
To better understand the molecular mechanism of 
inhibition of immunophilin/drug interactions, several 
groups have directed efforts towards determination of 
the three-dimensional structures of immunophilins and 
immunophilin/drug complexes [7-161. In this paper, we 
report the structure of 13C-labelled FK506 in the mon- 
omeric complex with human recombinant FKBP-12 
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(hrFKBP-12). Heteronuclear and isotope filtered exper- 
iments have been used to selectively observe and assign 
‘H signals arising from r3C-enriched FK506 bound to 
unlabelled hrFKBP- 12. Solution structures for bound 
FK506 have been generated by distance geometry meth- 
ods following quantitation of NOES from ‘“C-attached 
protons, and the structures refined by restrained molee- 
ular dynamics. 
2. MATERIALS AND METHODS 
Isotopically labelled FK506 was produced by growing Sfre~rortrjlres 
[17,18] in a fermentation medium containing uniformly labelled [“cl- 
glucose, The carbons of the pipecolic acid were not enriched because 
this moiety is biosynthetically derived entirely from amino acids. All 
other carbon sites contained 51% to 98% “C. hrFKBP-I2 was ex- 
pressed (S. Chambers, unpublished) and purified as described prcvi- 
ously [7]. The final NMR sample contained 5.3 mM FKSMIFKBP~12 
complex in 50 mM potassium phosphate buffer (90% HzO, 10% D:O) 
at pH 7.0. 
All NMR spectra wcrc collected at 303 K on a Bruker AMX-500 
spectrometer quipped with an X32 computer. Data were processed 
with Brukcr LIXNMR sohwarc, and peak integration wascarried out 
using the EASY (ETH Automated Spectroscopy) program [9]. HSQC. 
HMQC-TOCSY (r”, = 32 ms), and HSQC-NOESY (r, = 80 ms) spec- 
tra were collected in accordance with methods described in [20.21]. 
‘~C(o,)-‘~C(wl)-doublclalf-filter~ NQESY spectra (r, = 80 ms) 
were collected as described in [22,23]. Subspectra were combined on 
the X32 computer using in-house software. “C COSY, ‘H 2QF-COSY 
[24]. NOESY (t,, = 80 ms) [25], sensitivity-enhanced TOCSY (r, = 
70 ms) 1251, and double quantum (r, = 32 ms) [27,28]experimcnts were 
acquired using standard pulse sequences and phase cycling. 
The structure of FK506 was calculated from a scl of 66 NOES 
integrated in the HSQC-NOESY spectrum ;r,, = 80 ms). NOE inlen- 
sities were scaled to account for the level of “C enrichment and the 
number of attached protons. Some spindiffusion cffecls were ob- 
served, particularly between protons within ring systems. Accordingly. 
a conservative calibration of distance restraints was employed using 
NOES between neighboring methylenzs. L’ppc: bound co:rcc!ions 
were added to restruints involving pscudoatoms. Lower bounds of 
1.80 A were US& in all cws Based on the analysis of viGnal ‘ti-‘H 
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Fig. 1. Primary structure of FK506. Cambridge Data Base numbering 
is used. This numbering differs slightly from a previously published 
scheme [35,36], 
couplings within the pipecolinyl ring, dihedral angles were restrained 
to within r60° of values consistent with the chair conformation. 
Using these distance restraints, 200 initial structures were generated 
by using the DGII dislanw geometry Qorithm [29] with telrangle 
smoothing [30] within InsiyhtlI (Biosym Technologies). The SO DGII 
structures having the lowest error functions [29] were then subjected 
to restrained molecular dynamics refinement using Discover (Biosym 
Technologies). The system was heated to 1500 K over I ps, while 
increasing the force canstant for Ihe NMR restraints to 36 kcala 
mol-I 8 A-*. After equilibrating for 8 ps at 1500 K, the system was 
cooled exponentially to 300 K over 7 ps, followed by minimization in 
the presence of the NMR restraints. 
Although the final MD-refined structures had approximately equal 
restraint energies (all wilhin 0.1 kcal). these structures fell into two 
distinct families based upon total energy. The set of 43 lower energy 
structures comaincd 39 with a W,WIS amide conformation, while the 
second family, with 2-3 kcal higher total energy, consisted of seven 
structures, of which five possessed a cis amide geometry. Of the lower 
energy structures, the 39 with fruns amideconformation were sclccted 
for rmsd analysis. 
3. RESULTS AND DISCUSSION 
3.1. Assignrnenr of bound FK506 
The stepwise scalar connectivities observed in the 13C 
COSY spectrum (Fig. 2) formed the basis for assign- 
ment of the 13C and ‘H resonances of bound FKS06, 
HSQC, HMQC-TOCSY, and HSQC-NOESY spectra 
were used to obtain the chemical shifts of the attached 
protons. The three meihoxy resonances were disiin- 
guished by their intensities and lack of nearest-neighbor 
couplings and were assigned on the basis of NOES to 
the protons attached to the adjoining carbon. 
The 19C resonances of the nipecolic acid moiety (Cl 
to C6) could not be assigned because the carbons were 
not isotopically enriched. The pipecolinyl proton reso- 
nances, however, shift upfield dramatically upon bind- 
ing to FKBP-12 and are well resolved. Unambiguous 
patterns of scalar couplings and NOES provided dia- 
stereotopic proton assignments for all pipecolinyl pro- 
tons and indicated that the ring adopts a chair confor- 
mation, in agreement with an earlier study [31]. All 
chemical shift assignments are listed in Table I. 
In this work, HSQC-NOESY provided many more 
unambiguous intraligand NOES and better sensitivity 
than the double-half-filtered NOESY spectrum. Intra- 
ligand NOES were located in the HSQC-NOESY spec- 
trum by thei: characteristic square pattern of 
crosspeaks (Fig, 3). When the origins of NOES were in 
doubt, only those possessing a symmetry-related part- 
ner were used. Stereospecific assignments of methylene 
protons were made by comparing NOE intensities be- 
tween methylene and neighboring protons, using a set 
of initial structures (calculated using pseudoatoms) to 
provide relative distances. 
3.2. Conformation of bound FK506 
The network of NOE distance restraints used in the 
structure calculations is shown in Fig. 4. A number of 
long-lange NOE restraints were essential for defining 
the global conformation of the macrocycle. The posi- 
tion of the pyranose ring (C9-C13) was dictated by 
NOES from 42-OMe to 41”Me, and from 13-CH to 
24.CH and 41-Me. NOES from the pipecolinyl meth- 
ylene protons (C4-pro R, CS-pro S, C6-pro A and pro 
S) to 40.Me define its orientation, The local conforma- 
tion of the macrocycle backbone frovi Cl4 to C26 was 
defined by a series of medium range NOES. The relative 
position of the cyclohexane ring (C2S-C33) is well de- 
fined by NOES to the macrocycle, namely, 41-Me to 
28.CH and 30-CH, as well as a four-spin network of 
NOES from 2%CH and 33-CH: to 27-CH, and from 
27.CH to 23-CH. 
There are no protons in the region from Nl to C8, 
so local restraints are not available to define the confor- 
mation about the amide linkage (Nl_C?). The amide 
geometry is instead efined globally by NOES from the 
pipecolinyl ‘Gid-pyranose rings to 40.Me. In the final 
NMR structures, 39 of the 43 lowest energy structures 
exhibited the trans conformation, leading us to con- 
clude that this is the most likely conformation in solu- 
tion. 
The initial 50 DGII and final 39 MD-refined NMR 
structures of FK506 are shown in Fig. 5, top and mid- 
dle. None of the final structures contained more than 
two violations of the NOE restraints, nor any greater 
ihan 0. I ,&. The conformation of the bound ligand is 
very well defined: the average rmsd from the average 
structure is 0.28 8, for heavy atoms and 0.62 A for all 
atoms. The narrow conformational emelope occupied 
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Fig. 2. [‘HI “C COW spectrum at 125.76 MHz of “C-labelled FK506 bound to hrFKBP-12. Stcpwisc onnectivities are illuslrated for the 
macrocycle backbone carbons (Cl0 to C26) as well as the allylic group (C3S to C37), The carbonyl rcgior. (not shown) is folded in the FI dimension; 
circled crosspeaks arise from C9 and C22, which have folded into the displayed region. Experimental parameters are: spectral width. 33.333 Hr 
in ~2, 20,133 Hz in WI; 704 scans for each of 128 I, increments; WALTZ-16 hctero-decoupling [371 during I?. 
by the final structures is partly a consequence of the 
relatively high number of NMR restraints and the in- 
herently limited flexibility of the macrocycle ring. In 
addition, there is a tendency for energy minimization to 
produce structures that share a common, lowest energy 
conformation. 
Comparison of the average NMR structure with the 
x-ray structure [l l] (Fig. 5, bottom) reveals overall sim- 
ilarity. The only significant differences occur in the rc- 
gion of the ally1 group (C37 to C39). This group adopts 
multiple conformations in the family of refined struc- 
tures, ov;icg to its rapid motion szd the consequect 
absence of NOB restraints. Direct exponential evidence 
for the motional flexibility of this group is provided by 
the narrow linewidths of its NMR resonances, and the 
unusually weak intensity of the 3%CH to 39-CH2 
NOES. 
A slight difference is found in the position of the 
cjclohexyl ring relative to its orientation in the crystal 
structure. Prior to MD refinement, he DG structures 
exhibit 3 range of conformations for the cyclohexyl ring 
that encompasses the position found in the x-ray struc- 
ture (Fig. 5). MD simulations run in the presence of 
time-averaged restraints [32,33] indicate that the NOE 
restraints are insufficient o precisely define the orienta- 
tion of this ring, instead allowing it to pivot through a 
range of acg!es. Hence, the precise orieztetion of this 
ring in the final MD-refined NMR structures is appar- 
ently dictated partly by the MD force field. The applica- 
tion of time-averaged restraints to this system (D. 
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Fig, 3, HSQC-NOESY spectrum (r, = 80 ms) of “C-labelled FK506 bound !o hrFKEP-12, showing the upfield region. HSQC peaks are labclled 
according to carbon number. Pairs of mcthylene HSQC peaks are connected by brackets. The box illustrates a typical set of symmetry-related 
intraligand NOES. Spurious crosspeaks arising from intense protcin and pipccolinyl signals were identified on the basis of their distinctive 
appearance in the related HSQC and HMQC-TOCSY spectra. Experimental parameters are: spoztral width. 5,000 Hz in ~2, 27,672 Hz in 01; 64 
scans for each of400 I~ increments; GARP-2 hetero-decoupling [38] during I?. 
Pearlman, unpublished) will be discussed in detail elsc- 
where. 
A number of close contacts between FK506 and the 
side chains in the binding cleft of hr-FKBP-12 were 
evident in the HSQC-NOESY and ‘“C (01,02) double- 
half-filtered NOESY experiments. The ligand protons 
involved in these contacts are indicated in Fig. 4. Sev- 
eral FKBP-I2 side-chain spin systems were identified 
from 2D ‘H spectra, and tentative assignnmxs Were 
made by comparison with the published X-ray structure 
[ill. 
The large upfield shifts of the 3-CH, and 4-CM? pro- 
tons observed upon binding to hr-FKBP-12 provide 
evidence for their proximity to aromatic systems. Pro- 
tons located along the outside edge of pipecolinyl ring 
(3-, 4-, and 5-CH?) exhibit NOES to aromatic side 
chains located deep within the binding pocket. One of 
these nearby side chains gives rise to a distinctive set of 
four coupled resonances in COSY and DQ spectra (not 
shown), thus identifying it as Trp-59, in agreement with 
an earlier study [31]. Other NOES between the pip- 
ecolinyl group and aromatic protein resonances uggest 
interactions with ring protons of Tyr-82 and Tyr-26. 
One of the above-mentioned tyrosine ring spin sys- 
tems exhibits many NOES to the ligand, including lo- 
CH, 34.Me, and 1 l-CHz on the pyranose ring, and 
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Table I 
~H and ~C chemical shifts for FKS06 bound to hrFKBP-I 2 at pH 7.0 
and 303 K ~ 
Carbon chemical shifts (ppm) Proton chemical shifts (ppm) 
Site t3C shift ZH shifts 
1 .CO NA b 
2-CH NA 4.49 (eq) d 
3-CH: NA - I, 13 pro-S ¢ (ax) 
4-CH2 NA -1,91 pro-S (eq) 
5-CH2 NA -I,06 pro.R (ax) 
6.CH. NA 3,14 pro-R (eq) 
7-CO 169,8 
8-CO 199,3 
9.C ~ 100.1 
10-CH 36.4 1,56 
1 I-CH.. 34,2 1,28 pro-R 
12-CH 77,3 2,97 
13-CH 70,0 3,95 
14-CH 82,3 3,35 
15-CH: 29.5 1,55 pro-R 
16-CH 31,3 1,58 
17-CH: 47,4 1.84 pro-S 
18-C 143,1 
19-CH 124.7 4,81 
20-CH 52.6 3.76 
21-CO 212.2 
22-CH., 48.8 2.74 r 
23-CH 66.7 4.21 
24-CI'[ 38.5 1.69 
25-CH 90.0 5.32 
26-C 130.1 
Table I cont. 
Carbon chemical shifts (ppm) Proton chemical shifts (ppm) 
Site '3C shift ~H shifts 
27.CH 140.2 
28-CH 36,2 
29-CH: 36,2 
30-CH 85,4 
0.22 pro-R (eq) 31-CH 75,1 
-0,43 pro-R (ax) 32-CH2 34.0 
-0.75 pro.S (eq) 33-CH2 31,5 
34-Me 17.3 
-2.45 pro-S (ax) 35-M¢ 21.4 
36*Me 20. t 
37-CH., 35,6 
38-CH 138.0 
1,06 pro-S 39-CH: | 18.2 
40-Me 12, i
41-Me 12.1 
42.OMe 57.3 
0.80 pro-S 43-OMe 58.5 
44-OMe 85.4 
2,43 pro-g 
3,26 r 
5.36 
2.67 
0.82 
3.30 
3.42 
2.02 
1.15 
0.46 
1.02 
pro-R 
pro-S 
pro-R 
2.11 
2.27 t
5.81 
5.06 t ra~ 
0.'/9 
1.70 
3.36 
3.35 
3.30 
1.78 pro.S 
1.55 pro-R 
1.51 pro-S 
2.48 r 
5,12 c/s 
~H chemical shifts are referenced to H~O at 4.73 ppm and ~C shifts 
to external ["~C]acetate in phosphate buffer, 
~Not assigned, because the pila:colinyl carbons were not isotopicaily 
enriched. 
¢ pro.S and pro-S denote ~he stereo-specific assignments of prochiral 
ecntei's, 
a(ax) and (eq) denote axial and equatorial positions, 
quaternary carbon. 
r proton~ not stereo-specifically ssigned, 
Fig. 4. Ball and stick stereo representation f the average NMR structure. Distan~ r~train[s arc indim~ed by dashed lines. Pseudoatoms are 
depicted by mnall 0vtahcdrons, Ligand proto~s that exhibit NeE contacts with protein side chains are colored purple. 
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Fig. 5. (top) Stereoview of the 50 DGII structures with the lowest total error functions. Only heavy atoms arc shown. (middle) S~creoview of the 
39 MU-refined NMR structures with the loulcsr rota1 enec& cwJ lrutts anjide configumtians. Henry atoms are coded: carbon (blue), oxygen 
(yellow), nitrogen (green). (bottom) Stereoview of the average NMR structure (yeflow) supcrirrlpoxj upon the %ru”~itructurc ( yan) of rcfcrcnce 
[ll]. Only heavy atoms arc shown. 
41 -Me, 2%CH, 29-CH2, and 31-OMe on one edge of the 
cyclohexyl moiety. Examination of the crystal structure 
indicates that this tyrosine residue is most likely Tyr-82. 
Another aromatic spin system, identified as a phen- 
ylalanine on the basis of scalar couplings, gives rise to 
NOES to 16CH, 35-Me, 36-Me, and 41-Me. On the 
basis of the crystal structure, this residue is most likely 
Phe-46. These close contacts provide further evidence 
that the region of FK506 from C3 to Cl6 is involved in 
protein binding. On the other hand, no NOES are ob- 
served between the protein and the well-resolved reso- 
nances of the macrocycle in the region from 20-CH to 
23.CH, or from the allylic group, suggesting that this 
part of the molecule is exposed to solvent. The overall 
pattern of ligand/protein contacts agrees with that seen 
in previous X-ray crystallographic [ I!, 12,16] and NMR 
studies [ 15,343 of FKBP-lZ/ligand complexes. 
4. CONCLUSIONS 
In solution, FK506 binds to hrFKBP-12 in a single 
conformation closely resembling that seen in the X-ray 
structures. The principal exception is the ally1 region, 
which is more disordered in solution. In the X-ray struc- 
tures, this moiety packs against the ally1 group from a 
second, symmetry-related complex molecule in the unit 
cell [ 161, indicating that the high degree of order seen in 
the ally1 region of the X-ray structures is a consequence 
of crystallization. 
The fact that ally1 group mobility in solution differs 
from that observed in the crystal may be important in 
light of several recent findings. FK506 and rapamycin 
exhibit nearly identical contacts with FKBP-12 in the 
so-called binding region (which includes the pipecolinyl 
and pyranose rings), with the protein backbone differ- 
ing only slightly between the two complexes [11,12]. 
However, the FK506/FKBP-12 complex inhibits the 
Ca’+-dependent phqsphatase activity of calcineurin, 
while the rapamycin/FKBP- 12 and 506BD/FKBP- 12 
complexes do not [6]. Together, these findings suggest 
that the solvent exposed edge of FK506 (which includes 
the ally1 group) in the FK506/FKBP-12 complex could 
be part of a recognition site for the formation of a 
higher order complex with calcineurin. Drug design 
strategies based upon the crystal structure must there- 
fore allow for packing-induced istortions of the crucial 
aliy: region. 
Finally, our results indicate that caution is necessary 
when determining the conformation of bound ligands 
by restrained molecular dynamics. The conformation of 
a bound ligand is influenced by protein contacts and can 
obviously differ greatly from the lowest energy confor- 
mation of the unbound form. When restrained molecu- 
lar dynamics refinement is performed on a bound ligand 
in the absence of the receptor, the danger exists that 
regions of the ligand that are poorly restrained by 
NOES will adopt conformations that are influenced by 
the force field of the free ligand. Refinement methods 
that beter represent the limitations of the NOE re- 
straints, such as MD using time-averaged restraints 
[32,33], are a useful means to avoid overestimating the 
precision of the final structures. 
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